Article Information
History
- February 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniel B. Reeves1,2,*,
- Danielle N. Rigau3,
- Arianna Romero3,
- Hao Zhang4,
- Francesco R. Simonetti3,
- Joseph Varriale3,
- Rebecca Hoh5,
- Li Zhang6,
- Kellie N. Smith6,
- Luis J. Montaner7,
- Leah H. Rubin3,
- Stephen J. Gange3,
- Nadia R. Roan5,8,
- Phyllis C. Tien5,
- Joseph B. Margolick4,
- Michael J. Peluso5,
- Steven G. Deeks5,
- Joshua T. Schiffer1,9,
- Janet D. Siliciano3,
- Robert F. Siliciano3,10 and
- Annukka A. R. Antar3,11,**
- 1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle WA 98144 USA
- 2Department of Global Health, University of Washington, Seattle WA 98144 USA
- 3School of Medicine, Johns Hopkins University, Baltimore, MD 21205 USA
- 4Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205 USA
- 5School of Medicine, University of California San Francisco, San Francisco, CA 94158 USA
- 6Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21205 USA
- 7The Wistar Institute, Philadelphia, PA 19104 USA
- 8Gladstone Institutes, San Francisco, CA 94158 USA
- 9Department of Medicine, University of Washington, Seattle WA 98144 USA
- 10Howard Hughes Medical Institute, Baltimore, Maryland, USA